Pam3CSK4 is a toll-like receptor 1/2 (TLR1/2) agonist with an EC50 of 0.47 ng/mL for human TLR1/2
CAT No: P4102
CAS No:112208-00-1
Synonyms/Alias:Pam3CSK4;112208-00-1;(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2R)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid;Pam3Cys-Ser-(Lys)4;N-Palmitoyl-5,6-dipalmitoylcysteinyl-seryl-lysine(4);Pam3CSK4 TFA;P3C-SK4;P3CSK4;Pam(3)-Cys-Ser-(Lys)4;Pam(3)-Cys-Ser-Lys(4);SCHEMBL183536;CHEMBL506348;SCHEMBL25219115;AKOS024458265;AT35618;FP109571;(2S)-6-AMINO-2-[(2S)-6-AMINO-2-[(2S)-6-AMINO-2-[(2S)-6-AMINO-2-[(2S)-2-[(2R)-3-{[2,3-BIS(HEXADECANOYLOXY)PROPYL]SULFANYL}-2-HEXADECANAMIDOPROPANAMIDO]-3-HYDROXYPROPANAMIDO]HEXANAMIDO]HEXANAMIDO]HEXANAMIDO]HEXANOIC ACID;(N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2rs)-propyl]-[r]-cysteinyl-[s]-seryl-[s]-lysyl-[s]-lysyl-[s]-lysyl-[s]-lysine);L-Lysine, N2-(N2-(N2-(N2-(N-(S-(2,3-bis((1-oxohexadecyl)oxy)propyl)-N-(1-oxohexadecyl)-L-cysteinyl)-L-seryl)-L-lysyl)-L-lysyl)-L-lysyl)-;Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Lys-Lys-Lys-Lys-OH trifluoroacetate salt;
Chemical Name:(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2R)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More